ArticleCardiovascular diabetology2026
Systematic comparison of triglyceride-glucose (TYG)-index with other mortality predictive models in obese patients with different mortality rates.
Article in Cardiovascular diabetology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThe Triglyceride-Glucose (TYG)-Index has been increasingly used as a simple surrogate marker of insulin resistance and has been associated with adverse cardiometabolic outcomes in several populations. TYG has gained great attention as a predictive index for mortality, but comparisons with other predictive indexes are unexplored, except for TYG-derived indexes such as TYG-body mass index (TYG-BMI).
methodsWe conducted a comparative prognostic study in two independent cohorts of adults with obesity: a general obesity cohort (n = 1,359) and a bariatric surgery cohort (n = 854), both with long-term follow-up approaching 14 years and with different mortality rates (11.5 vs. 5.5%, respectively). We compared TYG index, TYG-BMI index, blood glucose, age, Charlson Index, metabolic syndrome, glucose tolerance, diabetes mellitus, through Cox proportional hazard models with Harrell'C index, and through ROC analysis. We also evaluated the possible incremental predictive value of the above prognostic indexes when combined with blood glucose, the TYG-index, and TYG-BMI index.
resultsAcross both cohorts, several metabolic and clinical indices were significantly associated with all-cause mortality in univariable analyses. However, age and Charlson Comorbidity Index consistently showed the strongest discrimination and prognostic performance. The various indexes significantly predicted mortality at Cox proportional hazard models (p always < 0.001). Harrell'C index correlated with ROC area under the curves of each index (p < 0.001), and both Harrell and ROC correlated with quality indexes of Cox analysis (LR, p < 0.001) and with quality indexes of linear regression (F, p < 0.001). Findings were directionally consistent in the bariatric surgery cohort, although lower event rates attenuated overall discrimination. The combined use of more indices together was not uniformly useful to increase the predictive value of the above indices.
conclusionIn obesity, TyG-based indices are associated with long-term mortality risk but add limited prognostic value beyond age and multimorbidity burden. These markers may be considered complementary tools for metabolic characterization rather than primary instruments for mortality risk stratification. This study reinforces the concept that various mortality indexes are as valid as, or even more predictive than, TYG index.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.